India to Cayman Islands: Daratumumab Export Trade Route
India has recorded 32 verified shipments of Daratumumab exported to Cayman Islands, representing a combined trade value of $125.7K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $3.9K USD. The leading Indian exporter is DOSHI MEDICARE PRIVATE LIMITED, which accounts for 79% of total export value with 23 shipments worth $98.7K USD. On the buying side, TO THE ORDER OF is the largest importer in Cayman Islands with $98.7K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Cayman Islands Daratumumab corridor is one of India's established pharmaceutical export routes, with 32 shipments documented worth a combined $125.7K USD. The route is dominated by DOSHI MEDICARE PRIVATE LIMITED, which alone accounts for roughly 79% of all export value, reflecting the consolidated nature of India's daratumumab manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $3.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with daratumumab's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 32.6%, placing it at rank #11 among India's top daratumumab export destinations globally.
On the import side, key buyers of Indian daratumumab in Cayman Islands include TO THE ORDER OF, TO THE ORDER OF THE PURCHASE MANAGE. TO THE ORDER OF is the single largest importer with 23 shipments valued at $98.7K USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#11
- Annual growth+32.6%
- Demand growth+29.0%
- Regulatory ease79/100
Top 10 Indian Daratumumab Exporters to Cayman Islands
Showing top 10 of 2 Indian suppliers exporting Daratumumab to Cayman Islands, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DOSHI MEDICARE PRIVATE LIMITED Avg $4.3K per shipment | 23 | $98.7K | 78.6% |
| 2 | MILES INTERNATIONAL Avg $3.0K per shipment | 9 | $26.9K | 21.4% |
This table shows the top 10 of 2 Indian companies exporting daratumumab to Cayman Islands, ranked by total trade value. The listed exporters are: DOSHI MEDICARE PRIVATE LIMITED, MILES INTERNATIONAL. DOSHI MEDICARE PRIVATE LIMITED is the dominant supplier with 23 shipments worth $98.7K USD, giving it a 79% market share.
Top 10 Daratumumab Importers in Cayman Islands
Showing top 10 of 2 known buyers in Cayman Islands receiving Daratumumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian daratumumab in Cayman Islands include TO THE ORDER OF, TO THE ORDER OF THE PURCHASE MANAGE. The largest importer is TO THE ORDER OF, accounting for $98.7K USD across 23 shipments — representing 79% of all daratumumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO THE ORDER OF | 23 | $98.7K | 78.6% |
| 2 | TO THE ORDER OF THE PURCHASE MANAGE | 9 | $26.9K | 21.4% |
Top 10 Daratumumab Formulations Imported by Cayman Islands
Showing top 10 of 23 product formulations shipped on the India to Cayman Islands Daratumumab route, ranked by trade value
Cayman Islands imports a wide range of daratumumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF THE PRODUCTS:DARZALEX FASPRO INJ ( DARATUMUMAB+HYALURONIDAS — accounts for $27.6K USD across 1 shipments. There are 23 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF THE PRODUCTS:DARZALEX FASPRO INJ ( DARATUMUMAB+HYALURONIDAS | 1 | $27.6K | 22.0% |
| 2 | MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF THE PRODUCTS DARZALEX 20ML 20MG ML INJ DARATUMUMAB PAC | 1 | $19.2K | 15.3% |
| 3 | MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF THE PRODUCTS:DARZALEX FASPRO INJ( DARATUMUMAB+HYALURONIDASE | 2 | $15.7K | 12.5% |
| 4 | MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF THE PRODUCTS:DARATUMUMAB DARZALEX 400 MG INJ,PACK:VIAL | 2 | $9.3K | 7.4% |
| 5 | [TAX INV.NO. THC000002] HARMLESS PHARMACEUTICAL PRODUCTS: DARATUMUMAB INJECTION(DARZALAX 400MG) | 1 | $8.5K | 6.8% |
| 6 | MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF THE PRODUCTS:DARZALEX 100MG INJ(DARATUMUMAB),PACK:VIAL | 4 | $6.7K | 5.3% |
| 7 | [TAX INV.NO. WH04779; GSTIN. 27AACCN8725E1ZF] DARATUMUMAB INJECTION (DARZALEX 400)VLS | 1 | $6.0K | 4.8% |
| 8 | MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF THE PRODUCTS:DARATUMUMABDARZALEX(20ML) 20MG/ML INJECTION | 1 | $4.0K | 3.2% |
| 9 | MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF THE PRODUCTS: DARATUMUMAB DARZALEX 400 MG INJ,PACK:VIAL | 1 | $3.5K | 2.8% |
| 10 | MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF THE PRODUCTS:DARZALEX(20ML) 20MG/ML INJ( DARATUMUMAB ),PACK: | 2 | $3.5K | 2.8% |
Showing top 10 of 23 Daratumumab formulations imported by Cayman Islands on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 76%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 15 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's daratumumab exports to Cayman Islands are driven primarily by a handful of large-scale manufacturers. DOSHI MEDICARE PRIVATE LIMITED with 23 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Cayman Islands benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — DOSHI MEDICARE PRIVATE LIMITED, MILES INTERNATIONAL — together account for 100% of total trade value on this route. The average shipment value of $3.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as medicines for consumption and the description of the products darzalex 20ml 20mg ml inj daratumumab pac and medicines for consumption and the description of the products:darzalex faspro inj( daratumumab+hyaluronidase, suggesting that buyers in Cayman Islands tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO THE ORDER OF is the largest importer with 23 shipments worth $98.7K USD — representing 79% of all daratumumab imports from India on this route.
Route Statistics
- Trade Volume
- $125.7K
- Avg. Shipment
- $3.9K
- Suppliers
- 2
- Buyers
- 2
- Transit (Sea)
- ~29 days
- Annual Growth
- +32.6%
Related Analysis
Other Daratumumab Routes
Unlock the Full India to Cayman Islands Daratumumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 32 shipments on this route.
Frequently Asked Questions — India to Cayman Islands Daratumumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Daratumumab to Cayman Islands?
The leading Indian exporters of Daratumumab to Cayman Islands are DOSHI MEDICARE PRIVATE LIMITED, MILES INTERNATIONAL. DOSHI MEDICARE PRIVATE LIMITED holds the largest market share at approximately 79% of total trade value on this route.
Q What is the total value of Daratumumab exports from India to Cayman Islands?
India exports Daratumumab to Cayman Islands worth approximately $125.7K USD across 32 recorded shipments. The average value per shipment is $3.9K USD.
Q Which ports does India use to ship Daratumumab to Cayman Islands?
The most active port of origin is SAHAR AIR with 15 shipments. Indian exporters primarily use sea freight for this route, with 76% of shipments going by sea and 23% by air.
Q How long does shipping take from India to Cayman Islands for Daratumumab?
The average transit time for Daratumumab shipments from India to Cayman Islands is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Cayman Islands Daratumumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 32.6% with demand growth tracking at 29.0%. The route is ranked #11 among India's top Daratumumab export destinations globally.
Q How many suppliers are active on the India to Cayman Islands Daratumumab route?
There are currently 2 active Indian suppliers exporting Daratumumab to Cayman Islands. The market is moderately concentrated with DOSHI MEDICARE PRIVATE LIMITED accounting for 79% of total shipment value.
Q Who are the main importers of Daratumumab from India in Cayman Islands?
The leading importers of Indian Daratumumab in Cayman Islands include TO THE ORDER OF, TO THE ORDER OF THE PURCHASE MANAGE. TO THE ORDER OF is the largest buyer with 23 shipments worth $98.7K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Cayman Islands export trade corridor identified from Indian Customs (DGFT) records for Daratumumab.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 2 importers in Cayman Islands matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 32 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
32 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists